Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines

Publication: Research - peer-reviewJournal article – Annual report year: 2009

View graph of relations

The recent unexpected observation that complement activation helps turnout growth and progression has an important bearing on the future development of cancer nanomedicines for site-specific tumour targeting as these entities are capable of triggering complement. These issues are discussed and suggestions are provided for future design and development of safer and effective cancer nanomedicines.
Original languageEnglish
JournalMolecular Immunology
Publication date2009
Volume46
Issue8-9
Pages1571-1572
ISSN0161-5890
DOIs
StatePublished
CitationsWeb of Science® Times Cited: 10

Keywords

  • Complement system, Nanoparticles, C5a, Cancer
Download as:
Download as PDF
Select render style:
APAAuthorCBEHarvardMLAStandardVancouverShortLong
PDF
Download as HTML
Select render style:
APAAuthorCBEHarvardMLAStandardVancouverShortLong
HTML
Download as Word
Select render style:
APAAuthorCBEHarvardMLAStandardVancouverShortLong
Word

ID: 3576406